Health
Romanian Pharmaceutical Market Rose 6.8% In 2014, To EUR2.7B
Sales of medicines in Romania rose 6.8% last year, to RON12.3 billion (EUR2.76 billion), higher than expected, according to Cegedim, which revised its forecast for 2015 from +1.8% to +3.5%.
Polisano Borrows EUR15M From BRD, Seeks Additional EUR15M To Fund Working Capital
Pharmaceutical distributor Polisano, owned by the Vonica family in Sibiu, has signed a new financing agreement for EUR15 million with BRD Societe Generale and is negotiation another EUR15 mi...
Dragos Damian Reelected Head Of Generic Meds Producers Association
The Association of Generic Medicine Producers in Romania (APMGR) has reelected Dragos Damian, executive manager of Terapia Ranbaxy, as its president, the association announced Friday.
Regina Maria Sale Likely To Bring The First EUR100M Deal In Romanian Healthcare
Regina Maria, a major player on Romania’s private healthcare market, is likely to change its owner this year in a deal likely to head toward nine figures in euros.
Ponderas Hospital Aims For 20% Growth In 2015
Bucharest’s Ponderas Hospital is due to have a more challenging period until September after relocation to a new space, double the previous one, but at yearend it is likely to register a 20%...
Regina Maria Eyes EUR67M Turnover, Invests In Expansion In 2015
Private medical service provider Regina Maria will invest over EUR5 million in expansion to new Romanian cities this year and estimates a turnover growth of over 20% to EUR67 million and an...
Wencz: Antitrust Authority Should Look Over Number Of Necessary Pharmacies In Romania
Romania's Competition Council should start an investigation over the pharmaceutical retail and find out the necessary number of pharmacies countrywide, which is currently at an unsustainable...
Ropharma 2014 Sales Up 2% To RON418.2M
Pharmaceutical company Ropharma Brasov (RPH.RO) reported sales worth 418.2 million lei (EUR94.2 million) in 2014, up 2% from RON411.2 million a year earlier, the company said Monday.
Zentiva 2014 Net Profit Rises 65% to RON61.5M
Romanian drugmaker Zentiva Bucharest (SCD.RO) posted a preliminary net profit of 61.5 million lei (EUR13.8 million) for 2014, up 65.3% compared with the previous year, following a significan...